APA

Wagener F. A. D. T. G., Dankers A. C. A., van Summeren F., Scharstuhl A., van den Heuvel J. J. M. W., Koenderink J. B., Pennings S. W. C., Russel F. G. M. & Masereeuw R. (20130930). Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity. : Current pharmaceutical design.

Chicago

Wagener Frank A D T G, Dankers Anita C A, van Summeren Frank, Scharstuhl Alwin, van den Heuvel Jeroen J M W, Koenderink Jan B, Pennings Sebastiaan W C, Russel Frans G M and Masereeuw Rosalinde. 20130930. Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity. : Current pharmaceutical design.

Harvard

Wagener F. A. D. T. G., Dankers A. C. A., van Summeren F., Scharstuhl A., van den Heuvel J. J. M. W., Koenderink J. B., Pennings S. W. C., Russel F. G. M. and Masereeuw R. (20130930). Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity. : Current pharmaceutical design.

MLA

Wagener Frank A D T G, Dankers Anita C A, van Summeren Frank, Scharstuhl Alwin, van den Heuvel Jeroen J M W, Koenderink Jan B, Pennings Sebastiaan W C, Russel Frans G M and Masereeuw Rosalinde. Heme Oxygenase-1 and breast cancer resistance protein protect against heme-induced toxicity. : Current pharmaceutical design. 20130930.